Topic: Liisa Bayko
Executives. . . . Richard E. T. Smith - Vice President, Investor Relations and Corporate Communications. . P. Schaefer Price - Chief Executive...
On Monday, there was a rise in share prices for companies who are studying potential new treatments for hepatitis C. This after Swiss drugmaker...
Savient Pharmaceuticals Inc. (SVNT) Q3 2010 Earnings Call October 26, 2010 8:30 am ET. In particular, we need to stress that when we discuss information regarding our efforts to identify strategic alternatives for the company, our preparations and plans to commercially ...
Incyte Corporation, (INCY) Q2 2010 Earnings Call August 05, 2010 8:30 am ET. On the call today are Paul Friedman, Incyte's President and Chief Executive Officer; Dave Hastings, Executive Vice President, Chief Financial Officer; Rich Levy, Executive Vice President, Chief ...
Idenix Pharmaceuticals, Inc. (IDIX) Q2 2010 Earnings Call Transcript July 26, 2010 4:30 pm ET. With me today are Jean-Pierre Sommadossi, CEO; Ron Renaud, CFO; Doug Mayers CMO; and David Standring, Executive Vice President, Biology.. Moving to the second quarter which ...
Mike Freeman - Associate Vice President, IR and Corporate Communications. With me today are Carolyn Logan, our President and Chief Executive Officer, and Adam Derbyshire, our Executive Vice President and Chief Financial Officer; and Dr. Bill Forbes, our Senior Vice President, Research and ...
ViroPharma Incorporated (VPHM) Q3 2009 Earnings Call Transcript October 28, 2009 9:00 am ET. With me on the call this morning are ViroPharma's management team, Vin Milano, Colin Broom, Tom Doyle, Bob Pietrusko, Charlie Rowland, and Dan Soland; Bob Doody ...
InterMune, Inc. (ITMN) Q2 2009 Earnings Call Transcript August 06, 2009 4:30 pm ET. On the call today are Dan Welch, InterMune's Chairman, Chief Executive Officer, and President; and John Hodgman, our Chief Financial Officer. Not only in the progress ...
Incyte Corporation (INCY) Q4 2008 Earnings Call Transcript February 18, 2009 8:30 am ET. On the call today are Paul Friedman, Incyte's President and Chief Executive Officer; Dave Hastings, Executive Vice President and Chief Financial Officer; and Rich Levy, Executive ...
Vertex Pharmaceuticals Incorporated (VRTX) Q4 2008 Earnings Call February 09, 2009 5:00 pm ET. Joining me on the call today to review Vertex's business priorities for 2009 are Dr. Freda Lewis-Hall, Ian Smith and Dr. Joshua Boger. Kurt Graves is ...
